A Closer Look At Combination Therapy For Chronic Wounds
- Volume 25 - Issue 7 - July 2012
- 9133 reads
- 0 comments
1. Available at http://www.plasticsurgery.org/Documents/medical-professionals/health-pol... . Published May 2007. Accessed June 11, 2012.
2. Fong J, Wood F. Nanocrystalline silver dressings in wound management: a review. Int J Nanomed. 2006; 1(4):441-9.
3. Kostenko V, Lyczak J, Turner K, Martinuzzi RJ. Impact of silver-containing wound dressings on bacterial biofilm viability and susceptibility to antibiotics during prolonged treatment. Antimicrob Agents Chemother. 2010; 54(12):5120-31.
4. Barnea Y, Weiss J, Gur E. A review of the applications of the hydrofiber dressings with silver (Aquacel Ag®) in wound care. Ther Clin Risk Manage. 2010; 6:21-7.
5. Simon A, Traynor K, Santos K, et al. Medical honey for wound care – still the ‘latest resort’? Evid Based Complement Alternat Med. 2009; 6(2):165-73.
6. O’Reilly D, Linden R, Fedorko L, et al. A prospective, double-blind, randomized, controlled clinical trial comparing standard wound care with adjunctive hyperbaric oxygen therapy (HBOT) to standard wound care only for the treatment of chronic, non-healing ulcers of the lower limb in patients with diabetes mellitus: a study protocol. Available at http://www.trialsjournal.com/content/12/1/69 . Published March 2011. Accessed June 11, 2012.
7. Kranke P, Bennett MH, Martyn-St James M, Schnabel A, Debus SE. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev. 2012; 4:CD004123.
8. Xie X, McGregor M, Dendukuri N. The clinical effectiveness of negative pressure wound therapy: a systematic review. J Wound Care. 2010; 19(11):490-495.
9. De Leon JM, Driver VR, Fylling CP, et al. The clinical relevance of treating chronic wounds with an enhanced near-physiological concentration of platelet-rich plasma gel. Adv Skin Wound Care. 2011; 24(8):357-368.
10. Frykberg RG, Driver VR, Carman D, et al. Chronic wounds treated with a physiologically relevant concentration of platelet-rich plasma gel: a prospective case series. Ostomy Wound Management. 2010; 56(6):36-44.
11. Available at http://dermnetnz.org/procedures/bioengineered-skin.html . Accessed June 11, 2012.
12. Buchberger B, Follmann M, Freyer D, et al. The evidence for the use of growth factors and active skin substitutes for the treatment of non-infected diabetic foot ulcers (DFU): a health technology assessment (HTA). Exp Clin Endocrinol Diabetes. 2011; 119(8):472-479.
13. Papanas N, Eleftheriadou I, Tentolouris N, Maltezos E. Advances in the topical treatment of diabetic foot ulcers. Curr Diabetes Rev. 2012; epub ahead of print.